Director/PDMR Shareholding

RNS Number : 9963Y

GlaxoSmithKline PLC

19 January 2022

 

GlaxoSmithKline plc   (the ' Company ')

Transaction notification

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Ms E Walmsley
b)	Position/status	Chief Executive Officer
c)	Initial notification/ amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Descriptionofthe financial instrument	Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
b)	Nature ofthe transaction	Acquisition of Ordinary Shares following the re-investment of dividends paid to shareholders on 13 January 2022 on Ordinary Shares held in the Company's Performance Share Plan subject to a 2-year holding period
c)	Price(s)and volume(s)	Price(s) Volume(s) £16.3120 7,618.203
d)	Aggregated information Aggregated volume Price	N/A (single transaction)
e)	Date ofthe transaction	2022-01-17
f)	Placeofthe transaction	London Stock Exchange (XLON)

 

END

 

 

DSHEKLFFLFLFBBX